| Title | Author(s) | Year | View Count |
 | AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma | Xu, MZ; Chan, SW; Liu, AM; Wong, KF; Fan, ST; Chen, J; Poon, RT; Zender, L; Lowe, SW; Hong, W; Luk, JM | 2011 | 427 |
 | Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis | Ko, FCF; Chan, LK; Tung, EKK; Lowe, SW; Ng, IOL; Yam, JWP | 2010 | 605 |
| Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma | Liu, LX; Lee, NP; Chan, VW; Xue, W; Zender, L; Zhang, C; Mao, M; Dai, H; Wang, XL; Xu, MZ; Lee, TK; Ng, IO; Chen, Y; Kung, HF; Lowe, SW; Poon, RTP; Wang, JH; Luk, JM | 2009 | 367 |
| Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma | Xu, MZ; Yao, TJ; Lee, NPY; Ng, IOL; Chan, YT; Zender, L; Lowe, SW; Poon, RTP; Luk, JM | 2009 | 640 |
| An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer | Zender, L; Xue, W; Zuber, J; Semighini, CP; Krasnitz, A; Ma, B; Zender, P; Kubicka, S; Luk, JM; Schirmacher, P; Richard Mccombie, W; Wigler, M; Hicks, J; Hannon, GJ; Powers, S; Lowe, SW | 2008 | 36 |
 | An oncogenomics-based in vivo RNAi screen identifies new tumor suppressors in liver cancer | Zender, L; Xue, W; Zuber, J; Semighini, CP; Krasnitz, A; Ma, B; Zender, P; Kubicka, S; Luk, JMC; Schirmacher, P; McCombie, RW; Wigler, M; Hicks, J; Hannon, GJ; Powers, S; Lowe, SW | 2008 | 136 |
| Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach | Zender, L; Spector, MS; Xue, W; Flemming, P; CordonCardo, C; Silke, J; Fan, ST; Luk, JM; Wigler, M; Hannon, GJ; Mu, D; Lucito, R; Powers, S; Lowe, SW | 2006 | 227 |
| LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16- insensitive CDK4 oncogene | Yang, X; Sham, JST; Ng, MH; Tsao, SW; Zhang, D; Lowe, SW; Cao, L | 2000 | 73 |
|
